BR0103209A - Uso de ácido fitânico para o tratamento de diabetes - Google Patents

Uso de ácido fitânico para o tratamento de diabetes

Info

Publication number
BR0103209A
BR0103209A BR0103209-7A BR0103209A BR0103209A BR 0103209 A BR0103209 A BR 0103209A BR 0103209 A BR0103209 A BR 0103209A BR 0103209 A BR0103209 A BR 0103209A
Authority
BR
Brazil
Prior art keywords
treatment
phytanic acid
diabetes
phytanic
niddm
Prior art date
Application number
BR0103209-7A
Other languages
English (en)
Inventor
Beat Fluehamnn
Manuel Heim
Willi Hunziker
Peter Weber
Original Assignee
Roche Vitamins Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roche Vitamins Ag filed Critical Roche Vitamins Ag
Publication of BR0103209A publication Critical patent/BR0103209A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

Patente de Invenção: "USO DE áCIDO FITâNICO PARA O TRATAMENTO DE DIABETES". Esta invenção refere-se a um novo método de tratamento e/ou prevenção de preferência de diabetes mellitus não-dependente de insulina (NIDDM ou chamada do tipo II), ou outras condições associadas com tolerância debilitada à glicose tal como obesidade, e em particular ao uso de derivados do ácido fitânico para o referido tratamento e/ou prevenção.
BR0103209-7A 2000-08-04 2001-08-03 Uso de ácido fitânico para o tratamento de diabetes BR0103209A (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP00116848 2000-08-04

Publications (1)

Publication Number Publication Date
BR0103209A true BR0103209A (pt) 2002-03-26

Family

ID=8169446

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0103209-7A BR0103209A (pt) 2000-08-04 2001-08-03 Uso de ácido fitânico para o tratamento de diabetes

Country Status (6)

Country Link
US (2) US6784207B2 (pt)
JP (1) JP2002104964A (pt)
KR (1) KR100798217B1 (pt)
CN (1) CN1307989C (pt)
BR (1) BR0103209A (pt)
CA (1) CA2353805C (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10237571A1 (de) * 2002-08-13 2004-02-26 Biotronik Meß- und Therapiegeräte GmbH & Co. Ingenieurbüro Berlin Endovaskuläres Implantat mit aktiver Beschichtung
CN1313030C (zh) * 2002-08-23 2007-05-02 帝斯曼知识产权资产管理有限公司 包含生物素的新颖的营养药物性组合物
WO2004041257A2 (en) * 2002-11-07 2004-05-21 Dsm Ip Assets B.V. Novel nutraceutical compositions comprising epigallocatechin gallate
DE10335027A1 (de) * 2003-07-31 2005-02-17 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verwendung von Angiotensin II Rezeptor Antagonisten
JP2006527725A (ja) * 2003-06-17 2006-12-07 ディーエスエム アイピー アセッツ ビー．ブイ． フィタン酸またはその誘導体を含む局所用薬剤
US20050158329A1 (en) * 2004-01-21 2005-07-21 Ghosh Swapan K. Novel phytol derived immunoadjuvants and their use in vaccine formulations
JP4413065B2 (ja) * 2004-01-28 2010-02-10 健爾 西 画像表示装置および画像表示システム
CA2565363A1 (en) * 2004-05-06 2005-11-17 Robert F. Hofmann Use of targeted oxidative therapeutic formulation in treatment of diabetes and obesity
PT1814527E (pt) * 2004-11-05 2014-01-16 Boehringer Ingelheim Int Comprimido de bicamada compreendendo telmisartan e amlodipina

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5835505B2 (ja) * 1976-01-09 1983-08-03 エーザイ株式会社 Ｎ−（α−メチル−ベンジル）−脂肪酸アミド
DE3318989C2 (de) * 1982-05-28 1996-11-21 Eisai Co Ltd ß,gamma-Dihydropolyprenylalkoholderivate und diese enthaltende Arzneimittel und deren Verwendung
WO1997009039A2 (en) 1995-09-08 1997-03-13 The Government Of The United States Of America, Represented By The Secretary Of The Department Of Health And Human Services Composition comprising vitamin f
DE19644422C2 (de) 1996-10-25 2000-06-15 Stefan Schulz Verwendung von Terpenen zur Behandlung von Autoimmunkrankheiten und bei Transplantat-Abstoßungsreaktionen
US6552055B2 (en) * 1996-12-11 2003-04-22 Dana-Farber Cancer Institute Methods and pharmaceutical compositions for inhibiting tumor cell growth
US6436993B1 (en) * 1999-07-13 2002-08-20 The Salk Institute For Biological Studies Use of RAR antagonists as modulators of hormone mediated processes

Also Published As

Publication number Publication date
US6784207B2 (en) 2004-08-31
JP2002104964A (ja) 2002-04-10
US20040138181A1 (en) 2004-07-15
KR20020011926A (ko) 2002-02-09
CN1365667A (zh) 2002-08-28
KR100798217B1 (ko) 2008-01-24
US7179842B2 (en) 2007-02-20
CN1307989C (zh) 2007-04-04
CA2353805A1 (en) 2002-02-04
US20020082298A1 (en) 2002-06-27
CA2353805C (en) 2010-01-19

Similar Documents

Publication Publication Date Title
BR0009480A (pt) Soluções de poliuretano com unidades de estrutura de alcoxissilano
BR9809968A (pt) Aplicação de derivados tiazolidinadiona no tratamento da pcos e diabetes gestacional
WO1999043705A8 (en) N-terminally truncated glp-1 derivatives
BR9714130A (pt) 2-cianopirrolidinas n-substituìdas
BR9913284A (pt) Métodos para administrar peptìdeos insulinotrópicos
BRPI0509573A (pt) derivados de sulfonamida-tiazolpiridina como ativadores de glicocinase úteis para o tratamento de diabetes do tipo 2
CA2329004A1 (en) Combination of insulin sensitizer with anorectic for treating or preventing diabetes
NO985741D0 (no) Soda-kalk-silika glassblandinger og deres anvendelser
BR0207700A (pt) Método para tratar a diabete melito em um paciente em necessidade de tal tratamento, e, usos de um derivado de polipeptìdeo de insulina, e de um conjugado de polipeptìdeo de insulina-oligÈmero
EP2085086A3 (en) Method for treating congestive heart failure or diabetic nephropathy
NO945036L (no) Vandig materiale som inneholder en organisk peroksysyre
BR0116370A (pt) Composto, composição farmacêutica, uso de um composto, e, método de tratamento de uma doença ou condição mediada por hppar em um paciente.
BR9814698A (pt) Combinação de um inibidor da aldose-redutase com um inibidor do glicogênio-fosforilase
BG103671A (en) Combinations of sulphonylcarbamide-glytazone having synergetic effect for the treatment of diabetes
BR9911666A (pt) Combinação farmacêutica, uso da combinação, processo para tratamento de uma doença inflamatória em uma pessoa sofrendo de ou susceptìvel a tal doença, e, composição farmacêutica
NO20071144L (no) Middel for a tilveiebringe substrater basert pa cellulose og/eller stivelse med vannfrastotende og samtidig soppdrepende, antibakterielle, insektfrastotende og algemotvirkende egenskaper
BRPI0007487B8 (pt) difenil-uréias substituídas com w-carbóxi-arilas como inibidores de raf cinase
CA2267186A1 (en) Method of using cyclooxygenase-2 inhibitors in the treatment and prevention of neoplasia
BRPI0519106A2 (pt) compostos, uso destes, processo para sua fabricaÇço, composiÇÕes farmacÊuticas, mÉtodo para o tratamento e/ou profilaxia de doenÇas que sço associadas com a dpp-iv
BR0103209A (pt) Uso de ácido fitânico para o tratamento de diabetes
DK1145717T3 (da) Synergistisk virkning af glyburid og milrinon
WO2002006221A3 (en) Cyclylamine sulfonamides as beta-3 adrenergic receptor agonists
ATE378054T1 (de) Mittel zu linderung von hyperglykämie nach dem essen
BR9712705A (pt) Composição para o tratamento da asma, contendo loratadina e um descongestionante
BR0107902A (pt) Composto, composição farmacêutica, métodos para o tratamento de doenças, e para o tratamento e/ou prevençao de, condições mediadas por receptores nucleares, e diabetes e/ou obesidade, uso de uim composto, processo para a preparação de um composto, e, método para tratar diabetes de tipo i, diabetes de tipo ii, tolerância prejudicada à glucose, resistência à insolina ou obesidade

Legal Events

Date Code Title Description
B25A Requested transfer of rights approved

Free format text: DSM IP ASSETS B.V. (NL)

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) 8O, 10, 11, 13, 24 E 25 DA LPI

B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL.